BRT provides rodent-based models (mouse and rat) to evaluate immune function, host resistance, and therapeutic efficacy. Our in vivo capabilities support customized study designs across immune safety, infectious disease, hypersensitivity, immunopharmacology, and specialized disease models.
BRT offers specialized rodent models across immune safety, host resistance, therapeutic efficacy, hypersensitivity, and other areas of preclinical research.
Viral, bacterial, and fungal models to evaluate host defense, immune function, and therapeutic response.
Rodent studies and integrated immune function assessments to evaluate immunotoxicity, immune modulation, and immune safety.
Customized in vivo studies to evaluate therapeutic efficacy, pharmacologic response, and immune-related outcomes.
In vivo models for hypersensitivity, pulmonary responses, food allergy, histamine response, and related immune endpoints.
Humanized and immunocompromised mouse models supporting studies of human immune responses and therapeutic candidates.
Tumor and specialized inflammatory disease models to support customized efficacy and immune response studies.
In vivo studies can be integrated with ex vivo assessments to evaluate immune function and provide additional insight into treatment-related responses.
BRT supports a variety of dosing and exposure routes in mouse and rat studies to accomodate customized study designs and research objectives.
BRT works with clients to develop customized in vivo study designs based on specific research objectives, test articles, and endpoints. In vivo studies can be integrated with ex vivo and bioanalytical assessments to support individual program needs.
